|
Guidant Corp. announced it was issuing a recall on its implanted cardiac defibrillator on June 17, 2005. Affecting around 50,000 of the devices, the Guidant recall is linked to at least 45 failures of the device and the deaths of two patients.
FDA urges the recall of soft tissues developed by CryoLife. Contact a Cryolife soft tissue recall lawyer today if you or a loved one has received an implant of these potentially harmful soft tissues and learn more
about the side effects of the soft tissue. Click
here to contact a soft tissue recall lawyer today.
Nearly 900,000 implants are collected from donor cadavers and shipped
to hospitals for surgical use every year. One of the nation's leading
supplier of human tissue used in implants, CryoLife Inc. was forced
to destroy human
soft tissue after the FDA found the company was using inadequate
procedures and exposing patients to deadly fungal and bacterial
infections as a result. The human soft tissue implant had not been
properly handled and resulted in at least 26
serious infections in the patients.
CryoLife is unable to redistribute the tissue until the company
starts meeting federal standards. According to an FDA
commissioner, the agency "tried to work with CryoLife and get
them in compliance, but it just didn't work." The FDA was especially
concerned with the soft tissue from a cadaver CryoLife sent out
despite it being confirmed that harmful germs were present in tissue
samples they had obtained from the same donor. The FDA allowed CryoLife's
heart valves to remain, but inspectors are currently studying them
due to the reported problems of infection that continue to be made.
Unlike soft tissue, recalling heart valves will create more of an
impact due to its lack of alternative options in some instances,
especially with babies.
The CryoLife
recall order was an unusually strong move, but according to
the director of the division of case management in the FDA's Office
of Compliance and Biologics Quality, Dr. Mary Markley, the agency
found "significant violations from our regulations." CryoLife
is the nation's largest supplier of heart valves obtained from human
donors and processes 70% of the nation's heart valves and 90% of
vascular tissue. Patients who have received CryoLife soft tissue
or heart valve implants should consult their physicians and contact
us for more information from a tissue implant attorney.
|